AARP Hearing Center
CLOSE
Search
Popular Searches
Suggested Links
Flexible Work
AARP Skills Builder
Flexible Work
ON-DEMAND WEBINARS
Drug Prices
Social Security
Medicare & Medicaid
Caregiving
LONG-TERM CARE
State Guides
Prepare to Care Guides
End of Life
Home Technology
Get Happier
POSSIBILITIES OF AI
Leaving AARP.org Website
You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.
General Assembly Advances Bipartisan Legislation to Make Medicine More Affordable for Virginians
RICHMOND, Va. — The Virginia General Assembly took steps today to rein in prescription drug prices in the Commonwealth.
The Senate and House both passed bills to create a Prescription Drug Affordability Board (PDAB), which will allow Virginia to set reasonable rates for certain high-cost, burdensome prescription drugs.
“This legislation isn’t just about lowering the cost of living, it’s about lowering the cost of staying alive,” said AARP Virginia State Director Jim Dau. “We deeply appreciate the legislative leaders from both sides of the aisle who worked together on this bipartisan measure. We look forward to its full passage.”
The House passed HB 570, patroned by Del. Karrie Delaney (D-Fairfax), by a bipartisan 52-46 vote. The Senate passed SB 274, patroned by Sen. Creigh Deeds (D-Charlottesville) and co-patroned by Sen. Bill Stanley (R-Franklin), with bipartisan support by a 23-16 vote.
By establishing a PDAB, Virginia will be the ninth state to do so, joining Colorado, Maine, Maryland, Minnesota, New Hampshire, Ohio, Oregon and Washington. A PDAB would set cost limits on how much Virginia consumers will pay for certain medications. The board would be an independent body of health and medical experts who would use data-based strategies to lower prescription drug prices.
Last week, the House and Senate both unanimously passed legislation to increase transparency for pharmacy benefit managers (PBMs). The House unanimously passed Del. Atoosa Reaser’s (D-Loudoun) HB 1402 on Wednesday, and the Senate unanimously passed Sen. Jennifer Carroll Foy’s (D-Woodbridge) SB 660 on Thursday. The legislation would impose a $5,000 per day fine on unlicensed pharmacy benefit managers. It would increase reporting requirements to shed light on the rebates and fees collected by pharmacy benefit managers and strengthen enforcement provisions for PBMs that keep this information hidden.
The four bills now move to the opposite chambers for consideration.
